Latest News Archive
Please select Category, Year, and then Month to display items
20 December 2019
|
Story Thabo Kessah
|
Photo Thabo Kessah
Dr Deidré van Rooyen from the Centre for Development Support, Dr Jared McDonald (Department of History), Moodi Matsoso, and Bishop Billyboy Ramahlele with the mobile device.
In an effort to broaden the storytelling horizons and to answer to the demands of the Fourth Industrial Revolution, Community Engagement on the UFS Qwaqwa Campus recently launched the Digital Storytelling project, aimed at broadening access to good community stories.
“We have partnered with the Common Good First initiative to enhance the service that we provide as a department,” said Bishop Billyboy Ramahlele, Director: Community Engagement.
“We challenge all academics, support staff, the SRC and students in general, to take advantage of this channel to communicate their stories to the world,” he said.
Histories of royal families
“The digital documentation of the histories of the royal families in the Qwaqwa area is in the pipeline and will be conducted in partnership with the Department of History. We have come to realise that with times changing, the younger generation loses track of the precious histories, and this platform will help in preserving that,” he added.
Community Engagement coordinator, Moodi Matsoso, also revealed that space has been identified for the lab. “At the moment, we are operating on mobile digital storytelling devices, with all the necessary equipment such as tablets and cameras. However, we will soon have a fully-fledged lab on campus,” she said.
This project is co-funded by the Erasmus+ Programme of the European Union.
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology